TBC1D20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.494200E-01
Normal-vs-Stage2
4.364600E-01
Normal-vs-Stage3
1.158400E-01
Normal-vs-Stage4
5.604800E-01
Stage1-vs-Stage2
3.604600E-01
Stage1-vs-Stage3
7.484300E-02
Stage1-vs-Stage4
5.186800E-01
Stage2-vs-Stage3
2.797800E-01
Stage2-vs-Stage4
9.934200E-01
Stage3-vs-Stage4
4.888400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.321400E-01
Normal-vs-AfricanAmerican
4.464200E-01
Normal-vs-Asian
1.168960E-01
Caucasian-vs-AfricanAmerican
9.844600E-01
Caucasian-vs-Asian
1.536630E-01
AfricanAmerican-vs-Asian
2.866400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.788200E-01
Normal-vs-Female
4.003600E-01
Male-vs-Female
5.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.109800E-01
Normal-vs-Age(41-60Yrs)
9.898000E-01
Normal-vs-Age(61-80Yrs)
3.429200E-01
Normal-vs-Age(81-100Yrs)
1.125950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.554200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.192000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.628000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.393600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.723700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.682800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.123900E-02
Normal-vs-Daily Drinker
3.342800E-01
Normal-vs-Weekly Drinker
8.241200E-01
Normal-vs-Occasional Drinker
7.860600E-01
Normal-vs-Social Drinker
9.593800E-01
Non Drinker-vs-Daily Drinker
4.035000E-01
Non Drinker-vs-Weekly Drinker
1.869770E-02
Non Drinker-vs-Occasional Drinker
8.795800E-03
Non Drinker-vs-Social Drinker
3.023900E-03
Daily Drinker-vs-Weekly Drinker
1.850160E-01
Daily Drinker-vs-Occasional Drinker
1.402990E-01
Daily Drinker-vs-Social Drinker
6.693900E-02
Weekly Drinker-vs-Occasional Drinker
9.786000E-01
Weekly Drinker-vs-Social Drinker
6.540600E-01
Occasional Drinker-vs-Social Drinker
5.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.820600E-01
Normal-vs-Grade 2
9.738800E-01
Normal-vs-Grade 3
9.847400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.983800E-01
Grade 1-vs-Grade 3
9.673400E-01
Grade 1-vs-Grade 4
9.820600E-01
Grade 2-vs-Grade 3
7.827000E-01
Grade 2-vs-Grade 4
9.738800E-01
Grade 3-vs-Grade 4
9.847400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.401000E-01
Normal-vs-NonDiabetic
5.618000E-01
Diabetic-vs-NonDiabetic
2.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.080600E-01
Normal-vs-NoPancreatitis
5.080400E-01
Pancreatitis-vs-NoPancreatitis
5.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.535200E-01
Normal-vs-N1
4.727200E-01
N0-vs-N1
7.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.945000E-01
Normal-vs-TP53-NonMutant
6.557800E-01
TP53-Mutant-vs-TP53-NonMutant
2.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
